Connor, Clark & Lunn Investment Management Ltd.

Position in RCUS — Arcus Biosciences, Inc.

CIK 1596800 VANCOUVER, A1

Position in RCUS

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$6,084,309

+$1,240,433 QoQ

Shares Held

281,681

+38.6% QoQ

Ownership

0.224%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $703,286,486 across 100 Biotechnology names. RCUS ranks #28 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	251,711	$112,399,029
2	IONS	Ionis Pharmaceuticals Inc	874,089	$65,635,343
3	ARWR	Arrowhead Pharmaceuticals, Inc.	836,981	$52,478,708
4	MIRM	Mirum Pharmaceuticals, Inc.	479,476	$44,293,992
5	REGN	Regeneron Pharmaceuticals, Inc.	32,164	$24,851,192
6	AXSM	Axsome Therapeutics, Inc.	134,792	$22,782,543
7	SRPT	Sarepta Therapeutics, Inc.	1,019,951	$22,194,133
8	TERN	Terns Pharmaceuticals, Inc.	384,681	$20,280,382

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,084,309	281,681	+38.6%	Shares	Sole	2026-05-11
2025-12-31	$4,843,876	203,268	+136.2%	Shares	Sole	2026-02-10
2025-09-30	$1,170,388	86,058	+34.4%	Shares	Sole	2025-11-13
2024-12-31	$953,600	64,043	-69.9%	Shares	Sole	2025-02-10
2022-03-31	$6,714,169	212,743	-20.2%	Shares	Sole	2022-05-12
2021-12-31	$10,786,995	266,543	-2.2%	Shares	Sole	2022-02-10
2021-09-30	$9,505,806	272,607	+1.4%	Shares	Sole	2021-11-12
2021-06-30	$7,378,804	268,711	+22.6%	Shares	Sole	2021-08-12
2021-03-31	$6,153,030	219,125	+12.6%	Shares	Sole	2021-05-13
2020-12-31	$5,050,232	194,539	+126.2%	Shares	Sole	2021-02-16
2020-09-30	$1,474,279	86,014	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.